TB Research

Yield of a contact investigation among children living with drug-resistant TB patients.

S Sharma, S Patankar, M C Becerra, M Bhalla, K U Khayyam, P Sethi, J Furin

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2025-09

Abstract

<sec><title>BACKGROUND</title>Children are at risk of TB, especially if they are household contacts of someone newly diagnosed. Research is needed on outcome of paediatric household contacts of drug-resistant TB (DR-TB) index patients, where routine follow-up is usually offered instead of preventive treatment. We describe the yield of a contact investigation protocol implemented among children ages 0-14 years living with DR-TB patients.</sec><sec><title>METHODS</title>A single centre prospective cohort study was conducted to follow-up paediatric household contacts of newly diagnosed (within last 6 months) sputum-positive pulmonary DR-TB patients in New Delhi, India. The study conducted symptom screening, tuberculin skin testing, chest X-rays, and bacteriological testing at baseline and during the 1-year follow-up.</sec><sec><title>RESULTS</title>We found a high yield of TB disease at baseline and within the first four follow-up months, with 22/276 participants (8.0%) started on TB treatment. Of these 22, 7 were bacteriologically confirmed and 15 were clinically diagnosed. Of the 7 participants with bacteriologically confirmed TB, 5 were asymptomatic, suggesting symptom screening alone may not be effective.</sec><sec><title>CONCLUSION</title>We advocate for early screening and diagnosis coupled with TB preventive treatment, instead of rigorous follow-ups as means of preventing paediatric DR-TB in household contacts.</sec>.

MeSH terms

  • Humans
  • Child
  • Child, Preschool
  • Adolescent
  • Tuberculosis, Multidrug-Resistant
  • Contact Tracing
  • Infant
  • Male
  • Female
  • Prospective Studies
  • India
  • Tuberculin Test
  • Tuberculosis, Pulmonary
  • Sputum
  • Infant, Newborn
  • Follow-Up Studies
  • Antitubercular Agents
  • Family Characteristics